The American College of Prosthodontists (ACP) welcomes Gerald T. Grant, DMD, MS, FACP, as the organization's new vice president. Dr. Grant was sworn in during a virtual ceremony at the organization's 50th anniversary Annual Session, Nov. 1 to 7, 2020.

It's a great honor to be selected to be the Vice President of the ACP. I look forward to working with a great team to develop innovative programs, promote advanced technologies, and support our members," said Dr. Grant. "We have a diverse membership of educators, military, researchers, new graduates with new practices, and members with more established practices. We have challenges with new technologies, student debt, and the lasting effects of a pandemic. I look forward to working with leadership and members to address these and whatever else comes our way."

Dr. Grant currently serves as a professor and the Interim Assistant Dean of Advanced Technologies and Innovation, Associate Director of UofL Additive Manufacturing Institute of Science & Technology (AMIST) at the University of Louisville School of Dentistry.

Dr. Grant previously served in United States Navy for 33 years, where he was the Service Chief of the 3D Medical Applications Center, Department of Radiology at Walter Reed National Military Medical Center.

After receiving his DMD degree from the University of Louisville School of Dentistry, Dr. Grant completed a Certificate in Prosthodontics from the Naval Postgraduate Dental School in Bethesda, MD, a Master of Science from George Washington University, and a certificate in Maxillofacial Prosthetics from the Naval Postgraduate Dental School.

Dr. Grant is a Diplomate of the American Board of Prosthodontics, Fellow of the ACP, and has held several leadership positions within the ACP and other dental organizations. Dr. Grant's research is in the validation and applications of Advanced Digital Dental Technologies, virtual surgical applications, dental restoration and rehabilitation, Advanced Digital Applications in the design and fabrication of medical devices for craniofacial reconstruction, and recently in bio-printing/bio-fabrication.

About the ACP

The American College of Prosthodontists (ACP) is the association that represents the specialty of prosthodontics. Founded in 1970, the ACP is dedicated to advancing the art and science of prosthodontics and promoting the specialty to the public and dental professionals. For more information, consumers can visit GoToAPro.org and dental professionals can visit Prosthodontics.org.

SOURCE American College of Prosthodontists 

Simply Beautiful Smiles, the largest dental provider in the Delaware Valley, has named Joe McLaughlin Vice President of Acquisitions & Integration, as the company seeks to expand its footprint with the acquisition of additional top independent dental practices. A veteran of the dental industry with more than 37 years of experience, McLaughlin, who most recently served as Vice President of Operations, will have a dedicated focus on overseeing the successful business transition of practices into the Simply Beautiful Smiles family.

“Since joining Simply Beautiful Smiles more than 15 years ago, Joe has played a vital role in supporting the seamless integration of numerous practice acquisitions, with a collaborative, hands-on approach,” said Tim North, who was named CEO of Simply Beautiful Smiles in December. “As we look to acquire additional practices, his expertise and now dedicated focus on integration will be a tremendous asset, providing a smooth transition and onboarding for practitioners and staff alike.”

“Simply Beautiful Smiles enables dentists to focus their time and energies on their passion for patient care by alleviating the administration demands and ongoing pressures of the business side of the practice,” said McLaughlin. “I look forward to continuing to work closely with each dental practice as they come on board and help them build on their success with the support of our platform.”

About Simply Beautiful Smiles

Simply Beautiful Smiles was founded 20 years ago to redefine the patient experience, offering comprehensive treatment inclusive of health, wellness and beauty. Its team of deeply skilled and compassionate doctors employ advanced technologies and best-in-class equipment to deliver outstanding dental care and dramatically improve the patient experience by reducing chair-time and the number of visits. With more than 25 locations, Simply Beautiful Smiles is now the Delaware Valley’s largest dental provider, serving Central and Southern New Jersey, Eastern Pennsylvania, and Northern Delaware.   

TheraBase is a dual-cured, calcium and fluoride releasing, self-adhesive base/liner. TheraBase contains MDP, chemically bonds to tooth structure, and utilizes THERA technology. It is radiopaque allowing for effective identification on radiographs. Its dual-cure ability ensures the material will cure even in deep restorations where light cannot reach!

BISCO

1-800-247-3368

www.bisco.com

The Thomas P. Hinman Dental Meeting – one of the nation’s largest dental meetings – has announced its Hinman 2021 educational program, which includes more than 45 in-person courses and more than 40 virtual courses, including live Q&A with the speakers. The 2o21 Meeting will be held March 12-13 at the Omni Atlanta Hotel at CNN Center along with the option to join the meeting virtually.

“We’ve planned an exceptional program for Hinman 2021 that includes innovative live and virtual courses delivered by the world’s foremost dental experts,” said Dr. Robert J. O’Donnell, General Chair of Hinman 2021. “While observing social distancing and safety precautions, attendees can take advantage of hands-on participation courses, lectures, a scaled down exhibit hall and the keynote session. Whether they attend in person or virtually, registered professionals can meet their continuing education requirements, learn the latest developments in dentistry and connect with colleagues in new and exciting ways.”

Hinman’s livestreamed Keynote Session will be held Friday, March 12 from 12:30 to 1:30 p.m., with a viewing party option for in-person attendees at the College Football Hall of Fame. It will feature Air Force Colonel (Ret.) Nicole Malachowski, the first female Thunderbirds pilot and one of the first women to fly modern fighters in combat. As a leader, combat veteran, White House Fellow, and inductee into the Women in Aviation International Pioneer Hall of Fame, Nicole had a distinguished 21-year Air Force career. It came to an end when a devastating tick-borne illness left her unable to speak or walk for 10 months. Nicole will share how she fought back, and other stories from her career and personal life, that will inspire you to rethink the challenges you face every day.

In-Person Course Offerings

Beginning March 12 at 7 a.m., Hinman will offer more than 45 courses across two days. Course topics range from implant complications, sleep apnea and restorative challenges in seniors to opioid and vape usage, sedation and achieving five-star customer service in the practice. Speakers include: Dr. Mark Hyman, Dr. Harold Crossley, Dr. Randy Huffines, Dr. Sully Sullivan, Ms. Janice Hurley and Dr. Roger Levin, among others.

A Team Track designed for all dental team members on Friday, March 12 includes:

· “Team Track: Your Image, Your Brand, Your Success,” Fr204a, Ms. Janice Hurley, 10 to 11 a.m.

· “Team Track: A ‘360 Slam Dunk’ Guide for Successful Teams,” Fr204a, Dr. Mark Hyman, 11 a.m. to 12 p.m.

· “Team Track: Become a Scheduling All-Star,” Fr204b, Mr. Larry Guzzardo, 2 to 3 p.m.

· “Team Track: World Class Team,” Fr204b, Dr. Roger Levin, 3 to 4 p.m.

Hinman 2021 also will offer 10 in-person participation courses, including:

· #Fr101 – “Veneer Prep ‘BLUEPRINT’ Workshop – From Prep to Provisionals,” Dr. William Bruce II, March 12, 8 to 11 a.m.

· #Fr102 – “Botox and Dermal Filler Training with Cadaver Anatomy Review Workshop,” Dr. Gigi Meinecke, March 12, 8 a.m. to 6 p.m. (Repeated on Saturday #Sa108)

· #Fr103 – “Introduction to Implant Dentistry: Hands-On Placement with Models,” Dr. Michael Pruett, March 12, 8 a.m. to 5 p.m.

· #Fr104 – “Cardiopulmonary Resuscitation Re-Certification (CPR),” March 12, 10 a.m. to 12 p.m. and #Fr106, 2 to 4 p.m.

· #Fr111 – “Applications in Treating Sleep Apnea in Your Practice: Hands-On Workshop,” Dr. Mark Murphy, March 12, 2 to 5 p.m.

· #Sa107 – “Occlusal Equilibration: Why, When and How,” Dr. Todd Davis, March 13, 9 a.m. to 12 p.m.

· #Sa109 – “Diagnostic Waxing for Complex Cases,” Dr. Thomas McDonald, March 13, 1 to 4 p.m.

· #Sa110 – “Composite ‘STREAMLINED’ for Anterior and Posterior Restorations Workshop,” Dr. William Bruce II, March 13, 1 to 4 p.m.

· #Sa111 – “Atraumatic Extraction and Socket Grafting for the General Practitioner,” Dr. Lee Silverstein, March 13, 9 a.m. to 12 p.m.

Virtual Course Offerings

In addition to Hinman 2021’s in-person courses, more than 40 virtual courses will be offered simulive, which means they will be prerecorded and broadcast at a designated time during the Meeting with the speaker available in the chat and Q&A portion of the course. These courses will then be available on-demand through April 12.

Virtual course topics range from restoration challenges, COVID communications and new product demonstrations to pathologies, contemporary ceramics and pediatric dentistry. Speakers include: Dr. Gordon Christensen, Dr. Lee Ann Brady, Ms. Lois Banta, Dr. David Clark, Ms. Karen Davis, Dr. Michael Fling, Dr. Kenneth Hargreaves, Dr. Samuel Low and more.

Live Virtual Participation Course

Hinman 2021 also will offer its first live virtual participation course on Friday, March 12 from 2:30 to 5:30. Attendees will need access to a handpiece and curing light and will receive a supply kit in advance. Course#VFr100, “Better, Faster, Prettier Composites” will feature Dr. David Clark broadcasting live from his home office.

All virtual lectures are included in the registration fee. For in-person courses, attendees must register and pay in advance of the Meeting. There will not be an on-site registration option this year. For those who plan to attend the meeting in person, masks will be required and social distancing guidelines will be followed. Hinman is working closely with local and state officials to ensure the health and safety of attendees. Hinman’s COVID Policy can be found here.

To register for Hinman 2021 and learn more about the Meeting, please visit www.hinman.org and its social media channels.

The Hinman Tradition

The Hinman Dental Meeting is designed with a commitment to quality and professionalism and a high regard for the value of continuing education. The Meeting is sponsored by the Hinman Dental Society, a non-profit organization, and excess revenue is invested and gifted in the form of individual scholarships to dental, hygiene and assisting students and in contributions to institutions that foster dental education. For additional information about the Thomas P. Hinman Dental Meeting, visit Hinman.org or contact Hinman at (404) 231-1663.  

MouthWatch, LLC a leader in dentist-managed, patient-friendly teledentistry solutions, digital case presentation tools and intraoral imaging devices, recently recognized five teledentistry pioneers during its third annual Teledentistry Innovation Awards, affectionately known as the “Tellies”. The 2020 Tellie Awards were presented on Friday, February 5th, during a well-attended virtual event.

According to MouthWatch, LLC CEO and founder Brant Herman, “2020 presented significant challenges to dentistry and the world at large, but the year also marked a time of unprecedented growth and innovation in the teledentistry field. We weren’t about to let a pandemic prevent us from recognizing this year’s Tellie Awards winners, so we hosted a great virtual event instead.”

Just as in previous years, the purpose of the Tellie Awards is two-fold:

1) Highlight the many ways that teledentistry is being implemented across a broad spectrum of dental care including public health, private practice, and organizational settings.

2) Recognize individual, forward-thinking dental providers who are realizing the full potential for connected dental care technology and who are reshaping the practice of dentistry while improving the state of oral health across the country.

In past years, Teledentistry Innovation Awards winners were named in the following categories:

Dentist/Specialist, Dental Hygiene and Oral Health Program (non-profit or business). New for the 2020 Tellie Awards were two special COVID Response categories: COVID-19 Response/Provider and COVID-19 Response/Oral Health Program. Here are the five 2020 Tellie Awards winners:

Winner Name and Organization: Scott Howell, DMD, MPH / AT Still University/Arizona School of Dentistry & Oral Health

Award Category: Dentist/Specialist

Dr. Scott Howell developed a robust oral health program at AT Still University/Arizona School of Dentistry & Oral Health (ATSU-ASDOH). To date, this program has trained over 300 students in teledentistry. Students learn about how they can use the technology to reach a diverse patient population and evaluate digital records collected via teledentistry.

Dr. Howell’s program effectively pivoted during the pandemic by having students participate in one-week public health rotations. During this rotation, the students worked with diverse patients, including children in detention, children and adults with special needs, low-income seniors, and men in rehabilitation/reentry programs.

Winner Name and Organization: Jingjing Qian RDH, EA /Your Special Smiles PLLC

Award Category: Dental Hygiene

Jingjing Qian RDH, EA was instrumental in developing and implementing a COVID response – The Guided Oral Hygiene Program that continued to provide oral care to long-term care residents who would otherwise not have received these critical services.

Ms. Qian and her dentist, Dr. Brooke Fukuoka developed the “’Guided Oral Hygiene Program’ “through which caregivers were trained on how to gather information via teledentistry and then used live teledentistry interactions to help caregivers with patient-specific oral hygiene regimens.” During the COVID-19 pandemic, this teledentistry-enabled touchpoint was the only dental service many of these patients received for months.

Winner Name and Organization: University of Rochester Eastman Institute for Oral Health

Award Category: Oral Health Program (Non-Profit or Business)

The University of Rochester Eastman Institute for Oral Health has published significant studies on teledentistry. However, its accomplishments also include the real-world implementation of teledentistry in oral health programs that provide care to underserved patients in the Greater Rochester, NY region. The University’s innovative deployment of teledentistry is part of its long experience and successful track record in designing, implementing, and sustaining community-based oral health programs—including outreach programs that have been replicated nationwide.

Candidate Name and Business: Barry Raphael, DMD / The Raphael Center for Integrative Orthodontics

Award Category: COVID-19 Response – Provider

During the pandemic's peak, many dental clinicians were pausing dental procedures and maintenance appointments because face-to-face interactions posed a very real risk of COVID-19 transmission. Dr. Barry Raphael, a practicing orthodontist for over 30 years, decided to pivot instead of pause.

Before the COVID-19 pandemic, he had already been re-examining his traditional views on patient treatment and adopted a new integrative approach. With his patient's safety as a top priority, he implemented teledentistry. All intraoral photos are submitted remotely, new patient records are completed electronically, and all consultations are conducted through a web-based platform.

Winner Organization: Advantage Dental from DentaQuest Care Group

Award Category: COVID 19 Response – Oral Health Program

Advantage Dental and DentaQuest have long seen the value of teledentistry and how it can transform access to dental care. Teledentistry was long supported through Advantage Dental’s outreach and mobile programs.

The recent teledentistry rollout across their over 80 practice locations were even more crucial in addressing urgent care needs during COVID-19. Through virtual consultations facilitated with their providers and member service representatives, patients had easy access to experienced clinical assistance when practices were open only for emergencies.

As practices reopened, Advantage Dental saw the numbers reflect that their teledentistry platform improved the patient experience, saved time for patients and providers, and helped bring convenience for patients already facing access challenges. The long-term vision to roll out teledentistry as part of Advantage Dental’s services is well underway.

“We congratulate and thank this year’s Teledentistry Innovation Awards winners for their commitment to using teledentistry technology to make a tangible difference in improving access to care,” added Herman. “For those who were not able to attend our live virtual event, we invite you to watch the recording of the awards and in-depth winner interviews, which is available on demand.” Visit teledentistryinnovationawards.com/2020Live for 24/7 access.

About MouthWatch, LLC:

Headquartered in Metuchen, New Jersey, MouthWatch, LLC is a leader in innovative teledentistry solutions, digital case presentation tools and intraoral imaging devices. The company is dedicated to finding new ways to constantly improve the dental health experience for both patient and provider.

In 2020, MouthWatch was ranked #1303 in the 2020 Inc. 5000 list of the Fastest Growing Privately Held Companies. In addition, the company earned the following dental industry awards: The 2020 Cellerant Best of Class Award for TeleDent™, the provider-focused, patient-friendly teledentistry platform. TeleDent™ also won Dentistry Today Magazine’s 2020 Top Innovative Products Award. What’s more, the MouthWatch Intraoral Camera won the Dentaltown Magazine’s 2020 Dental Townie Choice Award™ as well as Dentistry Today Magazine’s Top 100 Products Award. For more information about MouthWatch, LLC and its innovative products, visit www.MouthWatch.com.

SprintRay, manufacturer of high-tech fabrication solutions for dental professionals, and BEGO, the Bremen-based dental materials specialist with over 130 years of dental experience and more than 20 years of expertise in the field of dental 3D printing, have formally announced their integration partnership. This new integration will see the VarseoSmile Crown plus and VarseoSmile Temp materials become available for use with the SprintRay Pro 3D printing ecosystem, starting in the US market.

Highlights:

  • SprintRay Pro is now validated for use with BEGO VarseoSmile Crown ^plus and VarseoSmile Temp 3D printing materials for definitive and temporary restorations.

  • BEGO VarseoSmile Crown ^plus , the world's first approved tooth-colored, ceramic-filled hybrid material, and SprintRay Pro will allow dental professionals to 3D-print definitive restorations like crowns, inlays, onlays, and veneers, which is a huge step forward for the industry.

  • SprintRay and BEGO have completed a joint validation project, validating the performance, accuracy, and workflow for the two materials and the SprintRay Pro55 and Pro95 3D printers, as well as the Pro Cure post-processing unit.

This expansion into the market for crowns represents a huge growth area for SprintRay and BEGO, with over 2.3 million crowns placed in the US last year.

SprintRay and BEGO have entered into a partnership at a watershed moment in dental 3D printing. Printer market penetration in the dental market is exploding, giving dental professionals access to rapid, customizable manufacturing methods. This materials validation will give all SprintRay Pro users the ability to rapidly 3D-print temporary and permanent crowns at an extremely low cost in a very short amount of time, delivering an outstanding experience to their patients.

BEGO VarseoSmile Crown ^plus features outstanding mechanical properties on par with traditional crown materials. This means that patients can receive same-day crowns, 3D printed by their dentists, all at only a few dollars in materials cost to the practice.

"BEGO has been innovating in dentistry since 1890, and we're inspired by their continued commitment to market disruption," said Amir Mansouri, CEO of SprintRay. "Validating VarseoSmile materials means that our community will be able to offer rapid, cost-effective, high-quality solutions to their patients. This is a new frontier for dental 3D printing, one that times perfectly with the arrival of the SprintRay Pro55, which is perfect for fabricating restorative applications."

Compared to traditional methods of manufacturing crowns, which may include chairside mills or analog techniques, the VarseoSmile materials in conjunction with SprintRay 3D printers offer incredible value, speed, and customizability. With the timely introduction of SprintRay Pro55, clinicians can feel confident in the superior finish and fit of parts fabricated on the 55-micron XY resolution printer.

"Our collaboration with SprintRay contributes to our goal of making our Varseo 3D printing materials available to the widest possible range of users and our pioneering role and leading position in the dental 3D printing materials market," said Thomas Kwiedor, Head of Business Development 3D Printing.

As the 3D printing segment continues to grow, BEGO and SprintRay's partnership will help innumerable dental practices, laboratories and, most importantly, patients.

Keating Dental Lab has signed Dr. Mike DiTolla, accomplished dental educator and one of dentistry’s most entertaining speakers, to host its legacy “DentalUp!” weekly podcast, as well as direct and produce Keating’s new “Case of the Week” video series.

“Most dental podcasts feature dentists talking to other dentists about why they are so awesome at dentistry. Fair enough, but do we really need another one?” asks DiTolla. “One man has the courage to say NO! and it’s me. I’m the one man, in case that wasn’t clear.” Always looking to provide some levity in a profession as stressful as dentistry, Mike’s humor drives the podcast and its segments.

As host, Mike is fascinated by the personal and professional stories that dentists bring to the table. Mike’s guests share stories about their best and worst day as a dentist, their best and worst day as a speaker, and other unexpected, inspirational, and often highly entertaining personal anecdotes.  

Keating Dental Lab also signed Dr. DiTolla to produce “Case of the Week” videos, a format Mike popularized 15 years ago that continues to inspire dentists worldwide to send better work to their lab. “Dentists love seeing other dentists’ preps and impressions,” says DiTolla. “The best cases for ‘Case of the Week’ are the ones where the dentist did a lot of things right, but there is still a small issue or two,” explains DiTolla, “This gives Keating Dental Lab the opportunity to show that with personalized service and attention to detail, they can help the dentist get the desired result despite those small issues.”

To listen to the “Dental Up!” podcast, visit this link:

https://keatingdentallab.com/dental-up/podcast/

And to see the “Case of the Week” videos, visit:

https://keatingdentallab.com/videos/case-of-the-week-with-dr-mike-ditolla/

A recent survey commissioned by the American Association of Endodontists reveals that more than half of Americans say the COVID-19 pandemic has caused them to put off general dental check-ups, which can lead to serious oral health problems. The survey also showed that the pandemic is takings its toll on those working or studying remotely when it comes to changes to their daily dental hygiene routine. Significant findings include:

-31% were snacking more on sweets

-28% didn't schedule or forgot to schedule a dental visit

-1 in 4 said they waited until later in the morning to brush their teeth, while 21% didn't brush in the morning at all

-There was also a major drop off in flossing, with 24% saying they're flossing less frequently, while 23% say they aren't flossing

-Millennials more frequently reported experiencing dental disruptions, with 43% of those surveyed indicating that working from home or attending virtual classes from home led to disruptions to their usual dental hygiene habits during the COVID-19 pandemic lockdown.

Clearly, the pandemic is causing a major disruption in Americans' dental habits, which is leading to more serious tooth problems. Fortunately, it appears much of the public understands the importance of facing serious dental issues head on: Even with the pandemic, 60% say experiencing tooth pain that won't go away would lead them to make a dental appointment. The survey also asked about tooth loss versus procedures to save a bad tooth, with four out of five people stating that it's better to go the root canal route versus extraction.

When it comes to tooth pain, it's important to know that an endodontist is a toothache sufferer's greatest ally. It's also important to remember that it is extremely safe to visit the endodontist in the era of COVID-19, with endodontists practicing the utmost caution and disinfection protocol. Even at the height of the U.S.'s COVID-19 shutdown period in the spring of 2020, most endodontic practices remained open to safely treat dental emergencies.

To keep emergency rooms clear, in the case of a dental emergency, you should continue to seek an endodontist instead of dialing 911.

To learn more, visit our newsroom and watch our video Tooth Wisdom on YouTube.

"If you're suffering with a toothache that wakes you up out of a sound sleep at night, or because you're eating hot or cold food, you need an endodontist," says Dr. Alan H. Gluskin, President of American Association of Endodontists. "You should not delay treatment."

About the American Association of Endodontists

The AAE is headquartered in Chicago and represents more than 8,000 members worldwide. Endodontics is one of 12 dental specialties formally recognized by the American Dental Association. The AAE, founded in 1943, is dedicated to excellence in the art and science of endodontics and to the highest standard of patient care. The Association inspires its members to pursue professional advancement and personal fulfillment through education, research, advocacy, leadership, communication and service. For more information about the AAE, visit the Association's website at aae.org. For more patient focused information, visit aae.org/patients.

SOURCE American Association of Endodontists

Dental professionals have long sought improvements in dental implant bridge stability, longevity, and esthetics. NobelProcera Zirconia Implant Bridge is a premium solution that provides individualized, high-end, implant-based restorations and services that seek to improve patient outcomes, esthetics, and implant longevity.

"Precision is a key feature for positive patient outcomes and implant longevity. The NobelProcera Zirconia Implant Bridge is cement-free, manufactured with high-strength material and is an excellent choice," said Prof. Dr. Markus B. Blatz from Philadelphia, Pennsylvania.

Made for esthetics

Available in 10 precisely matched VITA® shades, the NobelProcera Zirconia Implant Bridge is designed with esthetics in mind. It was designed for a smaller, angulated screw channel, with the new Omnigrip Mini Screwdriver to improve occlusal esthetics.

With the recent partnership with DOCERAM Medical Ceramics, the zirconia implant bridges are produced with the high-end Nacera® Pearl zirconia material, which meets Nobel Biocare's highest quality standards.

Complete design flexibility

The new offering is available in full-contour, cut-back, thimble, and framework styles (with or without soft tissue), making it possible to achieve natural looking restorations. The combination of the angulated multi-unit abutment and angulated screw channel provides up to 55 degrees of restorative freedom.

Cement-free

Removing cement from the equation saves time and simplifies the process of implant bridge procedures.

High precision and material strength

NobelProcera works to achieve the goals of improved stability, durability, and esthetics through a manufacturing process that prioritizes high material strength and superior precision.

NobelProcera Zirconia Implant Bridge is now available in DTX Studio™ Lab and 3Shape® systems.

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company's portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive® and NobelParallel™), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), digital solutions for treatment planning (DTX Studio™ suite) and guided surgery, as well as biomaterials (creos™ regenerative solutions). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials.

SOURCE Nobel Biocare Usa, Inc. 

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced its intention to spin off the Company's Spine and Dental businesses to form a new and independent, publicly traded company ("NewCo"). The planned transaction will enhance the focus of both Zimmer Biomet and NewCo to meet the needs of patients and customers and is expected to achieve faster growth and deliver greater value for all stakeholders.

As part of the third phase of ZB's ongoing transformation, we are changing the complexion of our business through active portfolio management in order to accelerate growth and drive value creation," said Bryan Hanson, President and CEO of Zimmer Biomet. "For Zimmer Biomet, the transaction is an important step toward shifting our portfolio mix to higher-growth markets where we have a clear path to leadership and right to win. We believe NewCo will thrive as an independent company with prioritized capital allocation to pursue strategic growth opportunities and investment strategies in the large and growing Spine and Dental markets. This planned transaction underscores our commitment to ensuring our long-term priorities remain aligned with shareholders' best interests as we drive the business forward to meet customer needs and advance our mission to alleviate pain and improve the quality of life for people around the world."

The planned tax-efficient spin-off of NewCo is expected to create value for all stakeholders by achieving the following key goals:

Create a stronger growth profile for each company with enhanced management focus, while better aligning resources and processes more directly with the strategic priorities of each business;Improve capital allocation based on the objectives of each independent company;

Reduce complexity and improve operating efficiencies; and provide each company with a compelling financial profile that more accurately reflects the strengths and opportunities of each business and as a result, offers investors a more targeted investment opportunity.

Zimmer Biomet to Sharpen Focus on High Growth, High Priority Areas in Knees, Hips, S.E.T. and CMFT

Following the spin-off, Zimmer Biomet will remain a leader in attractive segments within the orthopedics market, including Knees, Hips, Sports Medicine, Extremities and Trauma (S.E.T.), and Craniomaxillofacial and Thoracic (CMFT). With a total market of $43.5 billion, the Company has significant opportunities to capture growth and market share. The Zimmer Biomet portfolio includes highly innovative products, such as ROSA® Knee for robotically-assisted surgeries, the Persona® Primary, Partial, Cementless and Revision Knee Systems, Oxford® Partial Knee, mymobility® with Apple Watch®, OrthoIntel Intelligence Platform, the Avenir Complete™ Hip System, the G7® Acetabular Hip System, Comprehensive® Shoulder System, X Series™ Power Equipment and the Signature™ ONE Surgical Planner.

Zimmer Biomet expects the spin-off to result in an improved financial profile. The Company delivered 2019 and 2020 pro forma revenue totaling $6.96 billion and $6.128 billion, respectively. The transaction is expected to be accretive to revenue growth by approximately 50 basis points over the course of the Company's five-year strategic planning period, accelerate adjusted earnings per share growth and expand the Company's adjusted EBITDA and operating margins by approximately 125 basis points on a pro forma basis, making its adjusted margin profile compelling among med tech companies.

The Company will maintain its capital allocation priorities of maintaining its investment grade rating while continuing to invest in innovation and execute tuck-in acquisitions in attractive, higher growth markets.

NewCo to Leverage Comprehensive Portfolio of Established Brands and Products

NewCo will be well-positioned in the $21 billion combined global Spine and Dental markets that benefit from attractive fundamentals. The Spine portfolio addresses all areas of spinal surgery, with enabling technologies to drive pull-through of core spine sales. The most differentiated products include ROSA® ONE Spine, Mobi-C® Cervical Disc and The Tether™. The Dental business is a global leader in oral reconstruction and is well-positioned in premium segments of the dental market, including surgical, restorative and digital, and regenerative solutions. Key products include the T3® Implant, Tapered Screw-Vent® Implant System, Trabecular Metal™ Dental Implant, BellaTek® Encode Impression System and Puros® Allograft Particulate.

NewCo's 2019 and 2020 pro forma revenue totaled approximately $1.022 billion and $897 million, respectively, supported primarily by a broad geographic revenue base, with meaningful exposure for enhanced revenue growth and margin expansion coming from both established and emerging markets. NewCo is expected to benefit from free cash flow diversification and a capital structure supportive of innovation and investment. The Spine and Dental platforms will provide flexibility to pursue multiple avenues to accelerate growth and operating margins. The planned transaction will also position NewCo to commercialize key new product launches and existing product offerings with a focused execution strategy for each geography in which it operates. NewCo is expected to drive innovation and extend its competitiveness through product and technology enhancements fueled by optimized resource allocation and targeted deployment, enabling it to meet customer needs more directly.

Leadership

Bryan Hanson will continue to lead Zimmer Biomet as its President and CEO. The search for a NewCo CEO is in its final stages. The NewCo Board of Directors, management and headquarters will be announced as they are finalized.

Transaction DetailsThe transaction is intended to qualify as a tax-free distribution, for U.S. federal income tax purposes, to U.S. shareholders of new publicly traded stock in NewCo.

Zimmer Biomet is targeting completion of the spin-off in mid-2022, subject to the satisfaction of certain conditions including, among others, final approval of Zimmer Biomet's Board of Directors, receipt of a favorable opinion and Internal Revenue Service ruling with respect to the tax-free nature of the transaction, and the effectiveness of a Form 10 registration statement that will be filed with the U.S. Securities and Exchange Commission. There can be no assurance regarding the ultimate timing of the proposed transaction or that the transaction will be completed.

Advisors

J.P. Morgan is serving as lead financial advisor to Zimmer Biomet, with Guggenheim Securities serving as financial advisor. White & Case LLP is acting as legal advisor to Zimmer Biomet.

Conference Call and Webcast

Zimmer Biomet separately reported today fourth quarter and full-year 2020 financial results. The Company has posted an investor presentation to its website and will host a conference call today at 8:30 a.m. ET to discuss the results and today's announcement.

The presentation and live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be archived for replay following the conference call.

Individuals in the U.S. and Canada who wish to dial into the conference call may do so by dialing (888) 312-9837 and entering conference ID 7278985. For a complete listing of international toll-free and local numbers, please visit https://investor.zimmerbiomet.com. A digital recording will be available after the completion of the conference call, from February 5, 2021 to April 6, 2021. To access the recording, U.S. callers should dial (888) 203-1112 and international callers should dial +1 (719) 457-0820, and enter the Access Code ID 7278985.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.

We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com, or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including any statements about our forecasts, expectations, plans, intentions, strategies or prospects. All statements other than statements of historical or current fact are, or may be deemed to be, forward-looking statements. Such statements are based upon the current beliefs, expectations and assumptions of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially from the forward-looking statements. These risks, uncertainties and changes in circumstances include, but are not limited to, statements regarding the anticipated spin-off of our Spine and Dental businesses, the expected timetable for completing the transaction, the tax-free nature of the transaction, the future financial and operating performance of each company following the transaction, benefits and synergies of the transaction, strategic and competitive advantages of each company, and future growth and other opportunities for each company. There is no assurance that the proposed transaction will be completed, that our Board of Directors will continue to pursue the proposed transaction (even if there are no impediments to completion), or that the proposed transaction will be the most beneficial alternative considered. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from historical experience or our present expectations, including but not limited to risks and uncertainties regarding economic, competitive, governmental, regulatory and technological factors affecting our operations, markets, products, services, customers and suppliers, the impact of the COVID-19 pandemic, as well as any changes in or abandonment of the proposed transaction and our ability to satisfy the conditions to the proposed transaction, and such forward-looking statements are not guarantees of future performance. A further list and description of these risks and uncertainties and other factors can be found in our Annual Report on Form 10-K for the year ended December 31, 2019, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and our subsequent filings with the Securities and Exchange Commission (SEC). Copies of these filings are available online at www.sec.gov, www.zimmerbiomet.com or on request from us. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in our filings with the SEC. Forward-looking statements speak only as of the date they are made, and we expressly disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers of this press release are cautioned not to rely on these forward-looking statements since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary note is applicable to all forward-looking statements contained in this press release.